Celera and LabCorp(R) Announce Licensing Agreement to Commercialize Breast Cancer Testing Essays Read more about Celera and LabCorp(R) Announce Licensing Agreement to Commercialize Breast Cancer Testing Essays
Conversion Right Triggered for LabCorp's Liquid Yield Option(TM) Notes Due 2021 and Zero Coupon Convertible Subordinated Notes Due 2021 Read more about Conversion Right Triggered for LabCorp's Liquid Yield Option(TM) Notes Due 2021 and Zero Coupon Convertible Subordinated Notes Due 2021
LabCorp's Liquid Yield Option(TM) Notes Due 2021 And Zero Coupon Convertible Subordinated Notes Due 2021 To Accrue Contingent Cash Interest Read more about LabCorp's Liquid Yield Option(TM) Notes Due 2021 And Zero Coupon Convertible Subordinated Notes Due 2021 To Accrue Contingent Cash Interest
LabCorp is Scheduled to Present at the Lehman Brothers 2007 Global Healthcare Conference Read more about LabCorp is Scheduled to Present at the Lehman Brothers 2007 Global Healthcare Conference
LabCorp Announces $500 Million Stock Repurchase Program Read more about LabCorp Announces $500 Million Stock Repurchase Program
LabCorp is Scheduled to Present at the Cowen and Company 27th Annual Health Care Conference Read more about LabCorp is Scheduled to Present at the Cowen and Company 27th Annual Health Care Conference
LabCorp(R) Notified by Aetna of Contract Termination Read more about LabCorp(R) Notified by Aetna of Contract Termination
LabCorp is Scheduled to Present at the Susquehanna Financial Group Significant Investment Options in Healthcare Conference Read more about LabCorp is Scheduled to Present at the Susquehanna Financial Group Significant Investment Options in Healthcare Conference
Laboratory Corporation of America(R) Announces 2006 Fourth Quarter and Full Year Results Read more about Laboratory Corporation of America(R) Announces 2006 Fourth Quarter and Full Year Results
LabCorp(R) and ARCA Discovery Partner to Commercialize Companion Diagnostic for First Cardiovascular Personalized Medicine Read more about LabCorp(R) and ARCA Discovery Partner to Commercialize Companion Diagnostic for First Cardiovascular Personalized Medicine
